Us Empty Iv Bags Market Report: Market Size & Forecast 2026

The U.S. Empty IV Bags Market encompasses sterile, single-use flexible bags made primarily from polyvinyl chloride or non-PVC materials such as ethylene vinyl acetate, designed to hold and deliver intravenous fluids, drugs, and nutritional solutions. Valued at approximately $4.9 billion in 2023, the market is on a trajectory to reach roughly $6.299 billion in 2026 and approximately $8.8 billion by 2030, sustained by a CAGR near 8.6% over the forecast horizon. As the single largest country market in North America, the United States accounts for roughly one-quarter of global demand for empty IV bags, supported by a dense hospital network, widespread home-care infusion services, and a mature pharmaceutical packaging supply chain.

• •Market valued at ~$4.9 billion in 2023, ~$6.299 billion in 2026, targeting ~$8.8 billion by 2030 at a ~8.6% CAGR
• •United States holds approximately 22.4% of the global empty IV bags market share
• •North American regional market projected at a ~6.7% CAGR over the 2022-2028 period

Demand for empty IV bags is fundamentally tied to healthcare utilization trends, with the rising prevalence of chronic conditions, including diabetes, cancer, and gastrointestinal disorders, generating sustained demand for intravenous drug delivery and parenteral nutrition. An aging U.S. population increases the volume of inpatient admissions, surgical interventions, and long-term home-infusion therapy, all of which require reliable sterile IV bag supply. Additional tailwinds come from expanded insurance coverage, post-pandemic investments in hospital capacity, and growing adoption of ready-to-use pre-filled IV systems that simplify bedside preparation.

• •Aging demographics and rising chronic disease prevalence increase inpatient and home-care IV therapy volumes
• •Growth in surgical procedures and critical-care admissions drives demand for sterile IV fluid containers
• •Expanding parenteral nutrition and home-infusion markets broaden the addressable customer base beyond acute-care hospitals

The market is broadly segmented by material type, PVC and non-PVC (including EVA and polyolefin blends), bag capacity, and end-use channel covering hospitals, ambulatory surgical centers, home-care settings, and specialty clinics. North America as a whole constitutes the most developed regional market, with the United States overwhelmingly dominant within that region and expected to maintain primacy through at least 2028, reaching an estimated $2.06 billion in market value by that year. Canada and Mexico represent smaller but growing sub-markets, with cross-border trade in medical disposables supported by integrated North American supply chains and regulatory harmonization under USMCA frameworks.

• •United States dominates the North American sub-region and is projected to reach ~$2.06 billion in market value by 2028
• •U.S. market alone valued at ~$1.99 billion in 2023, growing at ~8.5% CAGR through 2030
• •Segments include PVC vs. non-PVC materials, multiple capacity ranges, and end-use channels spanning hospitals, ASCs, and home care

Who are the notable companies in the industry?

The empty IV bags market is characterized by a moderately consolidated competitive structure in which a limited number of large, vertically integrated manufacturers with global capacity compete alongside regionally focused specialty converters. The industry is supply-chain integrated, with leading producers controlling multiple stages from polymer resin compounding through film extrusion, bag forming, sterilization, and finished-goods distribution. Capacity is heavily concentrated in North America and key Asian manufacturing hubs, with a significant share of U.S. hospital supply originating from domestic or near-shore production to ensure just-in-time delivery and regulatory compliance under FDA standards.

• •Moderately consolidated market dominated by large vertically integrated producers spanning resin compounding through bag fabrication and sterilization
• •Competitive differentiation driven by material technology (PVC vs. non-PVC/DEHP-free), regulatory certifications, and supply-chain reliability
• •Manufacturing capacity concentrated in North America and select Asian production centers, with domestic U.S. capacity prioritized for hospital and critical-care supply chains

What are the recent trends and outlook?

The market is moving toward non-PVC, DEHP-free, and phthalate-restricted materials in response to evolving FDA guidance and hospital procurement policies favoring safer alternative polymers. Integrated ready-to-use (RTU) IV systems that combine pre-filled drug solutions with the delivery bag are gaining share in hospital pharmacies, reducing preparation errors and improving workflow efficiency. Sustainability is emerging as a secondary theme, with manufacturers exploring recyclable biopolymer films and reduced-plastic formulations to meet hospital environmental procurement targets. Looking ahead to 2030-2034, the U.S. market is expected to sustain mid-to-high single-digit growth, supported by continued healthcare spending, expansion of outpatient infusion services, and incremental technology upgrades in bag design and closure systems.

• •Shift toward non-PVC, DEHP-free, and phthalate-restricted bag materials driven by hospital procurement policies and FDA regulatory guidance
• •Ready-to-use (RTU) pre-filled IV systems gaining adoption in hospital pharmacies to reduce medication errors and improve efficiency
• •Sustainability and recyclable packaging trends prompting material innovation in biopolymer films and closure systems